Hypouricemic effect of the methanol extract from Prunus mume fruit in mice

References

• Carcassi A, Marcolongo R Jr, Marinello E, Riario-Sforza G, Boggiano C. (1969). Liver xanthine oxidase in gouty patients. Arthritis Rheum, 12, 17–20.
   PubMedGoogle Scholar
• Carroll JJ, Coburn H, Douglass R, Babson AL. (1971). A simplified alkaline phosphotungstate assay for uric acid in serum. Clin Chem, 17, 158–160.
   PubMed Web of Science ®Google Scholar
• Chao J, Terkeltaub R. (2009). A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. Curr Rheumatol Rep, 11, 135–140.
   PubMedGoogle Scholar
• Chen L, Wen YQ, Shi YL. (2007). Comparison of external application of liuhedan and diclofenac treatment of acute gouty arthritis. West China Med J, 22, 361–362.
   Google Scholar
• Chen LX, Schumacher HR. (2008). Gout: An evidence-based review. J Clin Rheumatol, 14, S55–S62.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Committee. (2010). Pharmacopoeia of the People’s Republic of China, Beijing, China: China Medical Science Press.
   Google Scholar
• Chuda Y, Ono H, Ohnishi-Kameyama M, Matsumoto K, Nagata T, Kikuchi Y. (1999). Mumefural, citric acid derivative improving blood fluidity from fruit-juice concentrate of Japanese apricot (Prunus mume Sieb. et Zucc). J Agric Food Chem, 47, 828–831.
   PubMedGoogle Scholar
• Dalbeth N, So A. (2010). Hyperuricaemia and gout: state of the art and future perspectives. Ann Rheum Dis, 69, 1738–1743.
   PubMedGoogle Scholar
• Hall IH, Scoville JP, Reynolds DJ, Simlot R, Duncan P. (1990). Substituted cyclic imides as potential anti-gout agents. Life Sci, 46, 1923–1927.
   PubMed Web of Science ®Google Scholar
• Hwa KS, Chung DM, Chung YC, Chun HK. (2011). Hypouricemic effects of anthocyanin extracts of purple sweet potato on potassium oxonate-induced hyperuricemia in mice. Phytother Res, 25, 1415–1417.
   PubMed Web of Science ®Google Scholar
• Kawahara K, Hashiguchi T, Masuda K, Saniabadi AR, Kikuchi K, Tancharoen S, Ito T, Miura N, Morimoto Y, Biswas KK, Nawa Y, Meng X, Oyama Y, Takenouchi K, Shrestha B, Sameshima H, Shimizu T, Adachi T, Adachi M, Maruyama I. (2009). Mechanism of HMGB1 release inhibition from RAW264.7 cells by oleanolic acid in Prunus mume Sieb. et Zucc. Int J Mol Med, 23, 615–620.
   PubMedGoogle Scholar
• Kim S, Park SH, Lee HN, Park T. (2008). Prunus mume extract ameliorates exercise-induced fatigue in trained rats. J Med Food, 11, 460–468.
   PubMed Web of Science ®Google Scholar
• Kono R, Okuno Y, Inada K, Tokuda A, Hashizume H, Yoshida M, Nakamura M, Utsunomiya H. (2011). A Prunus mume extract stimulated the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biosci Biotechnol Biochem, 75, 1907–1911.
   PubMed Web of Science ®Google Scholar
• Kutzing MK, Firestein BL. (2008). Altered uric acid levels and disease states. J Pharmacol Exp Ther, 324, 1–7.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Mayer MD, Khosravan R, Vernillet L, Wu JT, Joseph-Ridge N, Mulford DJ. (2005). Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am J Ther, 12, 22–34.
   PubMedGoogle Scholar
• Mohammad MK, Almasri IM, Tawaha K, Issa A, Al-Nadaf A, Hudaib M, Alkhatib HS, Abu-Gharbieh E, Bustanji Y. (2010). Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus. Pharm Biol, 48, 1376–1383.
   PubMed Web of Science ®Google Scholar
• Osada Y, Tsuchimoto M, Fukushima H, Takahashi K, Kondo S, Hasegawa M, Komoriya K. (1993). Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents. Eur J Pharmacol, 241, 183–188.
   PubMed Web of Science ®Google Scholar
• Pacher P, Nivorozhkin A, Szabó C. (2006). Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev, 58, 87–114.
   PubMed Web of Science ®Google Scholar
• Qiu J. (2007). ‘Back to the future’ for Chinese herbal medicines. Nat Rev Drug Discov, 6, 506–507.
   PubMedGoogle Scholar
• Seneviratne CJ, Wong RW, Hägg U, Chen Y, Herath TD, Samaranayake PL, Kao R. (2011). Prunus mume extract exhibits antimicrobial activity against pathogenic oral bacteria. Int J Paediatr Dent, 21, 299–305.
   PubMedGoogle Scholar
• Singh I, Bishnoi I, Agarwal V, Bhatt S. (2011). Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (=8 mm) nephrolithiasis. Urol Ann, 3, 75–81.
   PubMedGoogle Scholar
• Stamp LK, O’Donnell JL, Chapman PT. (2007). Emerging therapies in the long-term management of hyperuricaemia and gout. Intern Med J, 37, 258–266.
   PubMed Web of Science ®Google Scholar
• Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P. (2006). Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats. Mol Cell Biochem, 292, 39–44.
   PubMedGoogle Scholar
• Tsuji R, Koizumi H, Fujiwara D. (2011). Effects of a plum (Prunus mume Siebold and Zucc.) ethanol extract on the immune system in vivo and in vitro. Biosci Biotechnol Biochem, 75, 2011–2013.
   PubMed Web of Science ®Google Scholar
• Unno T, Sugimoto A, Kakuda T. (2004). Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers. J Ethnopharmacol, 93, 391–395.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang CP, Hu QH, Lv YZ, Zhang X, Ouyang Z, Kong LD. (2010). The dual actions of Sanmiao wan as a hypouricemic agent: down-regulation of hepatic XOD and renal mURAT1 in hyperuricemic mice. J Ethnopharmacol, 128, 107–115.
   PubMedGoogle Scholar
• Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K, Miyoshi T, Kondo K, Bando Y, Ohnishi Y, Tangoku A. (2009). Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer, 125, 952–960.
   PubMedGoogle Scholar
• Yin MC, Chan KC. (2007). Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J Agric Food Chem, 55, 7177–7181.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhu JX, Mo SF, Pan Y, Kong LD. (2006). Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol, 103, 357–365.
   PubMed Web of Science ®Google Scholar
• Zhao XH, Yang GH. (2002). Treatment for different types of gouty arthritis. J Practical Trad Chinese Internal Med, 16, 204.
   Google Scholar
• Zhu JX, Wang Y, Kong LD, Yang C, Zhang X. (2004). Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol, 93, 133–140.
   PubMed Web of Science ®Google Scholar